AIDS/HIV

Investigating the impact of evolving cannabis access and use on high-risk drug use behaviours and addiction treatment

Cannabis remains the most widely produced, trafficked and consumed illicit drug worldwide, and at this time Canada and many other countries are implementing alternative regulatory approaches to cannabis. While research on cannabis has traditionally focused on the harms of cannabis use, an emerging body of evidence suggests that cannabis use can also alter high-risk drug practices, such as reducing cocaine use, opioid use and associated overdose.

Primary Investigator: 
Award Type: 
Year: 
2019

HIV pre-exposure prophylaxis implementation to key priority populations across British Columbia: Towards HIV elimination

Co-leads:

Executive sponsor:

  • Mark Gilbert
    BCCDC

What are the barriers and facilitators to optimizing HIV Pre-Exposure Prophylaxis (PrEP) implementation in different geographies and priority populations across BC?

Year: 
2018
Subscribe to RSS - AIDS/HIV